Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate BioPharma’s Approach, Part 2
Crossref DOI link: https://doi.org/10.1177/2168479015618696
Published Online: 2016-12-30
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gough, Jacqueline
Wilson, Brett
Zerola, Mireille
Wallis, Phil
Mork, Laila
Knepper, David
Achenbach, Heather
Text and Data Mining valid from 2016-01-01
Article History
Received: 10 September 2015
Accepted: 2 October 2015
First Online: 30 December 2016